Closing the gap: research and care imperatives for adolescents and young adults with cancer. A report of the Adolescent and Young Adult Oncology Program Review Group. Bethesda, MD: National Cancer Institute; 2006.
2.
BleyerA, O'LearyM, BarrA, RiesL. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. Vol 06-5767. Bethesda, MD: National Cancer Institute; 2006.
3.
BülowS. Familial polyposis coli. Dan Med Bull., 1987; 34(1):1–15.
BjörkJ, AkerbrantH, IseliusL, AlmT, HultcrantzR. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scand J Gastroenterol., 1999; 34(12):1230–5.
6.
MallinsonEK, NewtonKF, BowenJ, et al.The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis. Gut., 2010; 59(10):1378–82.
7.
AretzS, StienenD, FriedrichsN, et al.Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat., 2007; 28(10):985–92.
8.
GrodenJ, GelbertL, ThliverisA, et al.Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet., 1993; 52(2):263–72.
9.
BjörkJA, AkerbrantHI, IseliusLE, HultcrantzRW. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis Colon Rectum., 2000; 43(12):1719–25.
10.
ZebrackBJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer., 2011; 117(10 Suppl):2289–94.
11.
GanzPA, SchagCC, HeinrichRL. The psychosocial impact of cancer on the elderly: a comparison with younger patients. J Am Geriatr Soc., 1985; 33(6):429–35.
12.
MerluzziTV, Martinez SanchezMA. Assessment of self-efficacy and coping with cancer: development and validation of the cancer behavior inventory. Health Psychol., 1997; 16(2):163–70.
13.
PendleyJS, DahlquistLM, DreyerZ. Body image and psychosocial adjustment in adolescent cancer survivors. J Pediatr Psychol., 1997; 22(1):29–43.
14.
van BalkomKA, BeldMP, VisschersRG, van GemertWG, BreukinkSO. Long-term results after restorative proctocolectomy with ileal pouch-anal anastomosis at a young age. Dis Colon Rectum., 2012; 55(9):939–47.
15.
DuncanRE, GillamL, SavulescuJ, WilliamsonR, RogersJG, DelatyckiMB. “You're one of us now”: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet., 2008; 148C(1):47–55.
16.
GjoneH, DisethTH, FausaO, NøvikTS, HeibergA. Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clin Genet., 2011; 79(1):35–43.
17.
WhitelawS, NorthoverJM, HodgsonSV. Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet., 1996; 33(7):540–3.
18.
MorV, AllenS, MalinM. The psychosocial impact of cancer on older versus younger patients and their families. Cancer., 1994; 74(7 Suppl):2118–27.
19.
ParsonsHM, HarlanLC, LynchCF, et al.Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol., 2012; 30(19):2393–400.
20.
BurkeME, AlbrittonK, MarinaN. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer., 2007; 110(11):2385–93.
21.
BleyerA, BuddT, MontelloM. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer., 2006; 107(7 Suppl):1645–55.
22.
StillerCA, KrollME, Pritchard-JonesK. Population survival from childhood cancer in Britain during 1978–2005 by eras of entry to clinical trials. Ann Oncol., 2012; 23(9):2464–9.
23.
O'ConnellJB, MaggardMA, LiuJH, EtzioniDA, LivingstonEH, KoCY. Do young colon cancer patients have worse outcomes?. World J Surg., 2004; 28(6):558–62.
24.
FerrariA, ThomasD, FranklinAR, et al.Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol., 2010; 28(32):4850–7.
25.
SargentDJ, MarsoniS, MongesG, et al.Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol., 2010; 28(20):3219–26.
